DB

Dina Burkitbayeva

Founder at PsyMed Ventures

Dina Burkitbayeva has extensive work experience, beginning with an internship at White & Case in 2010. Dina then interned at LePatner & Associates, LLP in 2009. In 2011, they worked as an Investment Banking Analyst for J.P. Morgan, and in 2012, they worked as a Business Analyst for McKinsey & Company. In 2015, they founded and became the CEO of TRU Book. In 2018, they worked at Product School as Head of Growth & Business Development and Lead Instructor, Blockchain & Cryptocurrencies Course for Managers. In 2019, they worked as an Investor for ATAI Life Sciences AG and as a Product Manager (Volunteer) for The Transformative Tech Lab. In 2020, they founded PsyMed Ventures and in 2021, they became the CEO & Co-founder of Freedom Biosciences.

Dina Burkitbayeva's education history includes a Master of Business Administration (MBA) from Harvard Business School (2013-2015), a JYA from the University of Oxford in Politics, Philosophy and Economics (2009-2010), a B.S. and B.A. from Cornell University in City & Regional Planning and Economics (2002-2006), a Coding for Managers Certificate from Product School in HTML, CSS, Javascript and Ruby on Rails (2017), and is currently a PhD Candidate in East West Psychology at the California Institute of Integral Studies (2020-2024). Dina also holds a Web Development Certificate from Product School (2017).

Location

San Francisco, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


PsyMed Ventures

PsyMed Ventures is a venture fund & syndicate investing in transformational technologies that elevate mental health & wellness: psychedelic medicine, neurotechnology, precision psychiatry and digital therapeutics.


Industries

Employees

1-10

Links